Videos

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss mental resilience during one’s breast cancer journey.

A comprehensive review of treatment options for patients with metastatic hormone-sensitive prostate cancer.

Alicia Morgans, MD, MPH, discusses androgen deprivation therapy and its role in treating prostate cancer.

Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.

Expert perspectives on the decision-making process for selecting frontline systemic therapy for patients with advanced renal cell carcinoma.

A urologic oncology fellow provides a comprehensive overview of systemic therapy options for patients with prostate cancer.

Expert perspectives on how clinical trials and real-world evidence contribute to treatment decisions in prostate cancer.

A comprehensive overview of systemic therapies available for the treatment of patients with advanced renal cell carcinoma.

Experts in the field of kidney cancer discuss the risk stratification process for renal cell carcinoma and its effect on prognosis.

An expert sat down with CURE® and discussed how stem cells are collected before a patient with myeloma undergoes a stem cell transplant.

The notion of ‘time toxicity’ causes patients with stage 4 melanoma to have less available time in their everyday lives because of appointments and treatments.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about the differences between genetic and genomic testing in breast cancer care.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about prognostic and predictive outcomes in breast cancer, and the options available as a result.

As part of its Speaking Out video series, CURE spoke with Juanita Miller, an ANGEL Advocate from the Tigerlily Foundation, about fear of recurrence after breast cancer.

A genitourinary oncologist provides insights on the treatment decision-making process and the roles of guidelines for prostate cancer.

An experienced public health and cancer researcher offers advice to patients newly diagnosed with prostate cancer and discusses barriers to access to care.

Merkel cell carcinoma made headlines with the death of Jimmy Buffett. It’s rare and dangerous, and cases are becoming more common.

Rashid K. Sayyid, MD, MSc, describes the staging and risk stratification process for patients with prostate cancer and their effect on prognosis.

Reginald Tucker-Seeley, MA, ScM, ScD, gives an overview of the screening and diagnosis process of prostate cancer.

Clinical insights on the typical presentation of kidney cancer and the diagnostic process.

Chandler H. Park, MD, and Tian Zhang, MD, MHS, give an overview of renal cell carcinoma (RCC) and outline disease risk factors, symptoms, and prevention strategies.

Tanning beds cause an increased risk of skin cancer among young people — especially those who have a family history of skin cancer.

As part of its Speaking Out video series, CURE spoke with Hannah-Lise Schofield of the Children’s Hospital of Philadelphia about the psychosocial needs of young patients with cancer and their families as well as how those needs change over time.

As part of its Speaking Out video series, CURE spoke with Bruce L. Levine of the University of Pennsylvania Perelman School of Medicine about advancements in treatments for pediatric cancer.

As part of its Speaking Out video series, CURE spoke Bruce L. Levine of the University of Pennsylvania Perelman School of Medicine about CAR-T cell therapy, what it means for young patients with cancer and what new horizons it has revealed for treatment.

As part of its Speaking Out video series, CURE spoke with Tom Whitehead, co-founder and president of the Emily Whitehead Foundation, about the process of seeking treatment and what resources are available for young patients with cancer and their families.

Dr Nour Abahadra of Memorial Sloan Kettering discusses the diagnosis, treatment, and management of metastatic triple negative breast cancer (TNBC). Patient guest, Shay Elkins, shares her experience, from discovering a rapidly growing tumor to navigating her diagnosis and treatment, highlighting the importance of personalized support and resources available online.

A two-time breast cancer survivor who was diagnosed with chronic lymphocytic leukemia in 2020 discussed her belief in the power of minimal residual disease testing.

While the recent approval of a Jemperli-based regimen was an exciting advancement in the endometrial cancer space, racial disparities still exist and need to be addressed, and expert said.